GSK Submits Cervarix? Licence Application To Japan’s Health Authorities

GlaxoSmithKline (GSK) announced that it has submitted a licence application for its cervical cancer candidate vaccine Cervarix? to the Japanese Ministry of Health, Labor and Welfare (MHLW). This is the first vaccine for the prevention of cervical cancer to be filed for approval in Japan.GSK’s cervical cancer candidate vaccine is formulated with a novel proprietary adjuvant system called AS04, intended to enhance immune response and increase duration of protection. [click link for full article]

More: continued here

Filed under: Cervical Cancer on October 5th, 2007

Comments are closed.

« Rabies Vaccine Development At UGA Receives NIH Grant Consumer Perceptions Of Links Between Local Foods, Climate Change, Food Safety »

Pharmacy Brand Name - Buy Brandname Drugs: Depending on your prescription needs, your savings could be significant if you order online.
Pills Source - Buy Drugs: Pill source
Pills Store Online - Buy Drugs: Pills sotre online
Pills 2 Me - Order RX Pills for You: Just select the medicines you need, fill in our medical questionnaire, and submit your order.
Privacy rx pills - : Get Privacy rx pills
RX Pharmacy Online - Buy Drugs: RX Pharmacy online
RX Pills Store - Buy Drugs: RX pills sotre
Ultracet PIlls - Ultracet PIlls: Get Ultracet PIlls
Rx Meds Online - Rx Meds Online: Medical Rx online
Rx store online - : Rx store online
Latest News...